Skip to main content

B 683 Pill - yellow round, 8mm

Pill with imprint B 683 is Yellow, Round and has been identified as Rabeprazole Sodium Delayed-Release 20 mg. It is supplied by Breckenridge Pharmaceutical, Inc.

Rabeprazole is used in the treatment of barrett's esophagus; erosive esophagitis; duodenal ulcer; duodenal ulcer prophylaxis; gerd and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for B 683

Rabeprazole sodium delayed-release 20 mg B 683

Rabeprazole Sodium Delayed-Release

B 683
20 mg
8.00 mm
Prescription only
Drug Class
Proton pump inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Breckenridge Pharmaceutical, Inc.
National Drug Code (NDC)
51991-0683 (Discontinued)
Inactive Ingredients
diacetylated monoglycerides, hypromellose phthalate (31% phthalate, 40 cst), magnesium oxide, magnesium stearate, mannitol, magnesium silicate, titanium dioxide, ferric oxide yellow, ammonia, ferrosoferric oxide, propylene glycol, shellac

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "B 683"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.